Related references
Note: Only part of the references are listed.Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis
Xiang Yu et al.
NATURE COMMUNICATIONS (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy (vol 170, 1109.e1, 2017)
Antoni Ribas et al.
CELL (2018)
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Hua Wang et al.
NATURE MATERIALS (2018)
Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2018)
Plasma membrane changes during programmed cell deaths
Yingying Zhang et al.
CELL RESEARCH (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
Manisha Singh et al.
NATURE COMMUNICATIONS (2017)
Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2017)
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Gao-Na Shi et al.
BIOMATERIALS (2017)
Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy
Mingjun Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells
Shu Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
In Vivo Visualization of Tumor Antigen-containing Microparticles Generated in Fluorescent-protein-elicited Immunity
Fei Yang et al.
THERANOSTICS (2016)
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
Geoffrey M. Lynn et al.
NATURE BIOTECHNOLOGY (2015)
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity
Natalie L. Trevaskis et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
The role of lymph node sinus macrophages in host defense
Mirela Kuka et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Dmitriy Zamarin et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Hybrid Melittin Cytolytic Peptide-Driven Ultrasmall Lipid Nanoparticles Block Melanoma Growth in Vivo
Chuan Huang et al.
ACS NANO (2013)
Melittin: A lytic peptide with anticancer properties
Goran Gajski et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2013)
Bee Venom Phospholipase A2 Induces a Primary Type 2 Response that Is Dependent on the Receptor ST2 and Confers Protective Immunity
Noah W. Palm et al.
IMMUNITY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Engineering synthetic vaccines using cues from natural immunity
Darrell J. Irvine et al.
NATURE MATERIALS (2013)
Role of the inflammasome in defense against venoms
Noah W. Palm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
Jose Pulido et al.
NATURE BIOTECHNOLOGY (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhihong Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
Neelesh R. Soman et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Materials engineering for immunomodulation
Jeffrey A. Hubbell et al.
NATURE (2009)
OPINION Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
Manuel N. Melo et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Bee venom modulates murine Th1/Th2 lineage development
S Nam et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Cholesterol inhibits the lytic activity of melittin in erythrocytes
H Raghuraman et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2005)
Host defense peptides as new weapons in cancer treatment
N Papo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Tumor-associated antigens: From discovery to immunity
JD Lewis et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2003)
Homing and cellular traffic in lymph nodes
UH von Andrian et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Share Paper
